Vorgun GM 0.3/3 is a powerful combination of Glimepiride (3 mg) Metformin (500 mg) and Voglibose (0.3 mg) designed for the effective management of type 2 diabetes mellitus. Glimepiride stimulates insulin secretion from the pancreas while Metformin enhances insulin sensitivity and reduces hepatic glucose production. Voglibose an alpha-glucosidase inhibitor slows carbohydrate absorption in the intestines further aiding blood sugar control. Together these medications provide a comprehensive approach to managing blood sugar levels and reducing the risk of diabetes-related complications.



Reviews
There are no reviews yet.